CB41685-22P - 0x0000000000006448

Healthy Males & Females

Rose

* Stipend may pay up to reflected amount.
Start Date: 
November 14, 2024 - 3:45pm
End Date: 
December 5, 2024 - 1:15pm

Study Details

Study Number: CB41685
Group Number: 22P
Study Requirement: Healthy Normal Male and Female
Stipend: up to $12,100.00

Study Criteria

Age: 19 - 65
BMI: 18.5 - 24.9
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat Ulcerative Colitis.
Route of Administration: Oral
Blood Draws: 30

Study Schedule

Schedule Type: Long Term
Study Length: 10 Night Stay, 1 Return & 1 Phone Call

Screening Dates:

Event Day Event Date
Thursday 11/7/2024

Doctor Exam Dates:

Event Day Event Date
Thursday 11/7/2024

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 11/14/2024 3:45:00 PM Sunday 11/24/2024 10:15:00 AM 1 Phoenix
Return Tuesday 11/26/2024 9:15:00 AM Tuesday 11/26/2024 10:15:00 AM 1 Phoenix
Phone participant Thursday 12/5/2024 1:15:00 PM 1 Phoenix